Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 7Phase 1 6Phase 1/2 4Phase NA 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2Small Cell Lung Carcinoma 1Liver Neoplasms 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Self Expandable Metallic Stents 3Gemcitabine 2Dietary Supplements 2surufatinib 1durvalumab 1Yoga 1Whey Proteins 1Walking 1Trace Elements 1Saline Solution 1Radiofrequency Ablation 1Poly(ADP-ribose) Polymerase Inhibitors 1Pancreaticojejunostomy 1Immune Checkpoint Inhibitors 1Folfox protocol 1Exercise 1Ethanol 1Duodenoscopes 1Congresses as Topic 1Cisplatin 1Cholangiopancreatography, Endoscopic Retrograde 1Catheter Ablation 1Capecitabine 1Blood Specimen Collection 1Bevacizumab 1Anti-Bacterial Agents 1Anesthesia, Local 1Actigraphy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Biliary Tract Neoplasms × durvalumab × Clear all
NCT06611345 2024-10-26

A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers

Jiangsu Healthy Life Innovation Medical Technology Co., Ltd

Phase NA Recruiting
60 enrolled
Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡